Lung cancer in HIV-infected patients in the combination antiretroviral treatment era

Por Moltó, José, Moran, Teresa, Sirera, Guillem, Clotet, Bonaventura
Publicado no Transl Lung Cancer Res (2015)

The epidermal growth factor receptor (EGRF) in lung cancer

Por Carcereny, Enric, Morán, Teresa, Capdevila, Laia, Cros, Sara, Vilà, Laia, de los Llanos Gil, Maria, Remón, Jordi, Rosell, Rafael
Publicado no Transl Respir Med (2015)

A survey of engagement and competence levels in interventions and activities in a community mental health workforce in England

Por Lang, Linda, Orton, Sophie, Sallah, David, Hewitt-Moran, Teresa, Zhang, Dongmei, Cullen, Sean, Dixon, Sheila, Bell, Brian, Bell, David, Meeson, Lesley, Chen, Ruoling
Publicado em 2011

Targeting EML4-ALK driven non-small cell lung cancer (NSCLC)

Por Morán, Teresa, Quiroga, Vanesa, Gil, María de los Llanos, Vilà, Laia, Pardo, Nuria, Carcereny, Enric, Capdevila, Laia, Muñoz-Mármol, Ana M, Rosell, Rafael
Publicado no Transl Lung Cancer Res (2013)

Transbronchial and transesophageal fine-needle aspiration using a single ultrasound bronchoscope in the diagnosis of locoregional recurrence of surgically-treated lung cancer

Por Sanz-Santos, José, Serra, Pere, Andreo, Felipe, Torky, Mohamed, Centeno, Carmen, Morán, Teresa, Carcereny, Enric, Fernández, Esther, García-Reina, Samuel, Ruiz-Manzano, Juan
Publicado no BMC Pulm Med (2017)

ROR1 as a novel therapeutic target for EGFR-mutant non-small-cell lung cancer patients with the EGFR T790M mutation

Por Karachaliou, Niki, Gimenez-Capitan, Ana, Drozdowskyj, Ana, Viteri, Santiago, Moran, Teresa, Carcereny, Enric, Massuti, Bartomeu, Vergnenegre, Alain, de Marinis, Filippo, Molina, Miguel Angel, Teixido, Cristina, Rosell, Rafael
Publicado no Transl Lung Cancer Res (2014)

Customized chemotherapy in metastatic non-small cell lung cancer (NSCLC)

Por Wei, Jia, Moran, Teresa, Zou, Zhengyun, Qian, Xiaoping, Wang, Lifeng, Camps, Carlos, Hu, Wenjing, Chaib, Imane, Sanchez, Belén, Xu, Lixia, Karachaliou, Niki, Sanchez-Ronco, María, Liu, Baorui, Rosell, Rafael
Publicado no Transl Lung Cancer Res (2013)

Activity of dalotuzumab, a selective anti-IGF1R antibody, in combination with erlotinib in unselected patients with Non-small-cell lung cancer: a phase I/II randomized trial

Por Moran, Teresa, Felip, Enriqueta, Keedy, Vicki, Borghaei, Hossein, Shepherd, Frances A, Insa, Amelia, Brown, Holly, Fitzgerald, Timothy, Sathyanarayanan, Sriram, Reilly, John F, Mauro, David, Hsu, Karl, Yan, Li, Johnson, David H
Publicado no Exp Hematol Oncol (2014)

Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer

Por Simonetti, Sara, Molina, Miguel Angel, Queralt, Cristina, de Aguirre, Itziar, Mayo, Clara, Bertran-Alamillo, Jordi, Sanchez, José Javier, Gonzalez-Larriba, Jose Luis, Jimenez, Ulpiano, Isla, Dolores, Moran, Teresa, Viteri, Santiago, Camps, Carlos, Garcia-Campelo, Rosario, Massuti, Bartomeu, Benlloch, Susana, y Cajal, Santiago Ramon, Taron, Miquel, Rosell, Rafael
Publicado em 2010

EGFR Mutations and ALK Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non-Small Cell Lung Cancer (NSCLC): A Retrospective Analysis

Por Gainor, Justin F., Shaw, Alice T., Sequist, Lecia V., Fu, Xiujun, Azzoli, Christopher G., Piotrowska, Zofia, Huynh, Tiffany, Zhao, Ling, Fulton, Linnea, Schultz, Katherine R., Howe, Emily, Farago, Anna F., Sullivan, Ryan J., Stone, James R., Digumarthy, Subba, Moran, Teresa, Hata, Aaron N., Yagi, Yukako, Yeap, Beow Y., Engelman, Jeffrey A., Mino-Kenudson, Mari
Publicado no Clin Cancer Res (2016)

Customized Treatment in Non-Small-Cell Lung Cancer Based on EGFR Mutations and BRCA1 mRNA Expression

Por Rosell, Rafael, Perez-Roca, Laia, Sanchez, Jose Javier, Cobo, Manuel, Moran, Teresa, Chaib, Imane, Provencio, Mariano, Domine, Manuel, Sala, Maria Angeles, Jimenez, Ulpiano, Diz, Pilar, Barneto, Isidoro, Macias, Jose Antonio, de las Peñas, Ramon, Catot, Silvia, Isla, Dolores, Sanchez, Jose Miguel, Ibeas, Rafael, Lopez-Vivanco, Guillermo, Oramas, Juana, Mendez, Pedro, Reguart, Noemi, Blanco, Remei, Taron, Miquel
Publicado em 2009

Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1

Por Ohashi, Kadoaki, Sequist, Lecia V., Arcila, Maria E., Moran, Teresa, Chmielecki, Juliann, Lin, Ya-Lun, Pan, Yumei, Wang, Lu, de Stanchina, Elisa, Shien, Kazuhiko, Aoe, Keisuke, Toyooka, Shinichi, Kiura, Katsuyuki, Fernandez-Cuesta, Lynnette, Fidias, Panos, Yang, James Chih-Hsin, Miller, Vincent A., Riely, Gregory J., Kris, Mark G., Engelman, Jeffrey A., Vnencak-Jones, Cindy L., Dias-Santagata, Dora, Ladanyi, Marc, Pao, William
Publicado em 2012

Characteristics of Lung Cancers Harboring NRAS Mutations

Por Ohashi, Kadoaki, Sequist, Lecia V., Arcila, Maria E., Lovly, Christine M., Chen, Xi, Rudin, Charles M., Moran, Teresa, Camidge, D. Ross, Vnencak-Jones, Cindy L., Berry, Lynne, Pan, Yumei, Sasaki, Hidefumi, Engelman, Jeffrey A., Garon, Edward B., Dubinett, Steven M., Franklin, Wilbur A., Riely, Gregory J., Sos, Martin L., Kris, Mark G., Dias-Santagata, Dora, Ladanyi, Marc, Bunn, Paul A., Pao, William
Publicado em 2013

Structural, biochemical and clinical characterization of epidermal growth factor receptor (EGFR) exon 20 insertion mutations in lung cancer

Por Yasuda, Hiroyuki, Park, Eunyoung, Yun, Cai-Hong, Sng, Natasha J., Lucena-Araujo, Antonio R., Yeo, Wee-Lee, Huberman, Mark S., Cohen, David W., Nakayama, Sohei, Ishioka, Kota, Yamaguchi, Norihiro, Hanna, Megan, Oxnard, Geoffrey R., Lathan, Christopher S., Moran, Teresa, Sequist, Lecia V., Chaft, Jamie E., Riely, Gregory J., Arcila, Maria E., Soo, Ross A., Meyerson, Matthew, Eck, Michael J., Kobayashi, Susumu S., Costa, Daniel B.
Publicado em 2013

RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer

Por Niederst, Matthew J., Sequist, Lecia V., Poirier, John T., Mermel, Craig H., Lockerman, Elizabeth L., Garcia, Angel R., Katayama, Ryohei, Costa, Carlotta, Ross, Kenneth N., Moran, Teresa, Howe, Emily, Fulton, Linnea E., Mulvey, Hillary E., Bernardo, Lindsay A., Mohamoud, Farhiya, Miyoshi, Norikatsu, VanderLaan, Paul A., Costa, Daniel B., Jänne, Pasi A., Borger, Darrell R., Ramaswamy, Sridhar, Shioda, Toshi, Iafrate, Anthony J., Getz, Gad, Rudin, Charles M., Mino-Kenudson, Mari, Engelman, Jeffrey A.
Publicado no Nat Commun (2015)

BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer

Por Karachaliou, Niki, Codony-Servat, Jordi, Teixidó, Cristina, Pilotto, Sara, Drozdowskyj, Ana, Codony-Servat, Carles, Giménez-Capitán, Ana, Molina-Vila, Miguel Angel, Bertrán-Alamillo, Jordi, Gervais, Radj, Massuti, Bartomeu, Morán, Teresa, Majem, Margarita, Felip, Enriqueta, Carcereny, Enric, García-Campelo, Rosario, Viteri, Santiago, González-Cao, María, Morales-Espinosa, Daniela, Verlicchi, Alberto, Crisetti, Elisabetta, Chaib, Imane, Santarpia, Mariacarmela, Luis Ramírez, José, Bosch-Barrera, Joaquim, Felipe Cardona, Andrés, de Marinis, Filippo, López-Vivanco, Guillermo, Miguel Sánchez, José, Vergnenegre, Alain, Sánchez Hernández, José Javier, Sperduti, Isabella, Bria, Emilio, Rosell, Rafael
Publicado no Sci Rep (2015)